New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy.

Front Immunol · 2025 · PMC11794227 · PMID 39911396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The role of m 6 A methylation writers in liver cancer immunotherapy The relationship between m 6 A writers and liver cancer immunotherapy is multifaceted and highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.